Financhill
Back

Halozyme Therapeutics Quote, Financials, Valuation and Earnings

Halozyme Therapeutics Price Quote

$46.95
+0.02 (+-0.78%)
(Updated: December 21, 2024 at 5:29 AM ET)

Halozyme Therapeutics Key Stats

Buy
51
Halozyme Therapeutics (HALO) is a Buy

Day range:
$46.88 - $48.21
52-week range:
$33.15 - $65.53
Dividend yield:
0%
P/E ratio:
22.35
P/S ratio:
6.43
P/B ratio:
13.19%

Volume:
4.5M
Avg. volume:
2M
1-year change:
29%
Market cap:
$6B
Revenue:
$829.3M
EPS:
$3.02

How Much Does Halozyme Therapeutics Make?

Data Unavailable

Is Halozyme Therapeutics Growing As A Company?

Data Unavailable

Halozyme Therapeutics Stock Price Performance

What Is Halozyme Therapeutics 52-Week High & Low?

Halozyme Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Halozyme Therapeutics?

Data Unavailable

Is Halozyme Therapeutics Cash Flow Positive?

Data Unavailable

Halozyme Therapeutics Return On Invested Capital

Data Unavailable

Halozyme Therapeutics Earnings Date & Stock Price

Halozyme Therapeutics Competitors

Halozyme Therapeutics Dividend Yield

Data Unavailable

Halozyme Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 72.13% 27.05%
Revenue: 34.28% 15.04%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 64.00
Upside from Last Price: 36.37%

Major Shareholders

Data Unavailable